Industry: Medical Devices & Consumables
Published Date: 2025-04-18
Pages: 93 Pages
Report ld: 4713140
Request Sample
Customized Report
Endoscopic Bariatric Therapy Devices Market Size(US$)

CAGR 2025-2031
8.9%
Market Size,2031
USD 260
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Endoscopic Bariatric Therapy Devices was valued at US$ 151 million in the year 2024 and is projected to reach a revised size of US$ 260 million by 2031, growing at a CAGR of 8.9% during the forecast period.
Among the various developed Endoscopic Bariatric Therapy (EBT) devices, the intragastric balloon (IGB) is the most widely used in clinical settings. The IGB is inserted into the stomach via endoscopy, occupying space to reduce gastric volume and delay gastric emptying. This helps patients control appetite, reduce food intake, and facilitate weight loss. It is primarily indicated for individuals with a Body Mass Index (BMI) between 30 and 40 who have not achieved weight loss through diet and exercise, and it is also used as a bridge therapy before bariatric surgery. The IGB is reversible and typically removed endoscopically after six months. In recent years, advancements in technology have led to the development of next-generation EBT devices, such as adjustable balloons, biodegradable balloons, and endoscopic suturing techniques, providing safer, minimally invasive, and more personalized treatment options for obese patients.
North American market for Endoscopic Bariatric Therapy Devices is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Endoscopic Bariatric Therapy Devices is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Endoscopic Bariatric Therapy Devices include Boston Scientific (Apollo Endosurgery), ReShape Lifesciences, Allurion, Helioscopie, Endalis, MEDSIL, Spatz Medical, Lexel, Districlass Medical, Silimed, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Endoscopic Bariatric Therapy Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endoscopic Bariatric Therapy Devices.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Endoscopic Bariatric Therapy Devices competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The Endoscopic Bariatric Therapy Devices market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Endoscopic Bariatric Therapy Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Endoscopic Bariatric Therapy Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Boston Scientific (Apollo Endosurgery)
ReShape Lifesciences
Allurion
Helioscopie
Endalis
MEDSIL
Spatz Medical
Lexel
Districlass Medical
Silimed
Changzhou Panda Medical
Segment by Type
Intragastric Balloon
Others
Segment by Application
Male
Female
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Endoscopic Bariatric Therapy Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Endoscopic Bariatric Therapy Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Endoscopic Bariatric Therapy Devices Market Overview
1.1 Product Definition
1.2 Endoscopic Bariatric Therapy Devices by Type
1.2.1 Global Endoscopic Bariatric Therapy Devices Market Value Comparison by Type (2024 VS 2031)
1.2.2 Intragastric Balloon
1.2.3 Others
1.3 Endoscopic Bariatric Therapy Devices by Application
1.3.1 Global Endoscopic Bariatric Therapy Devices Market Value by Application (2024 VS 2031)
1.3.2 Male
1.3.3 Female
1.4 Global Endoscopic Bariatric Therapy Devices Market Size Estimates and Forecasts
1.4.1 Global Endoscopic Bariatric Therapy Devices Revenue 2020-2031
1.4.2 Global Endoscopic Bariatric Therapy Devices Sales 2020-2031
1.4.3 Global Endoscopic Bariatric Therapy Devices Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Endoscopic Bariatric Therapy Devices Market Competition by Manufacturers
2.1 Global Endoscopic Bariatric Therapy Devices Sales Market Share by Manufacturers (2020-2025)
2.2 Global Endoscopic Bariatric Therapy Devices Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Endoscopic Bariatric Therapy Devices Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Endoscopic Bariatric Therapy Devices, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Endoscopic Bariatric Therapy Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Endoscopic Bariatric Therapy Devices, Product Type & Application
2.7 Global Key Manufacturers of Endoscopic Bariatric Therapy Devices, Date of Enter into This Industry
2.8 Global Endoscopic Bariatric Therapy Devices Market Competitive Situation and Trends
2.8.1 Global Endoscopic Bariatric Therapy Devices Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Endoscopic Bariatric Therapy Devices Players Market Share by Revenue
2.8.3 Global Endoscopic Bariatric Therapy Devices Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Endoscopic Bariatric Therapy Devices Market Scenario by Region
3.1 Global Endoscopic Bariatric Therapy Devices Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Endoscopic Bariatric Therapy Devices Sales by Region: 2020-2031
3.2.1 Global Endoscopic Bariatric Therapy Devices Sales by Region: 2020-2025
3.2.2 Global Endoscopic Bariatric Therapy Devices Sales by Region: 2026-2031
3.3 Global Endoscopic Bariatric Therapy Devices Revenue by Region: 2020-2031
3.3.1 Global Endoscopic Bariatric Therapy Devices Revenue by Region: 2020-2025
3.3.2 Global Endoscopic Bariatric Therapy Devices Revenue by Region: 2026-2031
3.4 North America Endoscopic Bariatric Therapy Devices Market Facts & Figures by Country
3.4.1 North America Endoscopic Bariatric Therapy Devices Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Endoscopic Bariatric Therapy Devices Sales by Country (2020-2031)
3.4.3 North America Endoscopic Bariatric Therapy Devices Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Endoscopic Bariatric Therapy Devices Market Facts & Figures by Country
3.5.1 Europe Endoscopic Bariatric Therapy Devices Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Endoscopic Bariatric Therapy Devices Sales by Country (2020-2031)
3.5.3 Europe Endoscopic Bariatric Therapy Devices Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Endoscopic Bariatric Therapy Devices Market Facts & Figures by Region
3.6.1 Asia Pacific Endoscopic Bariatric Therapy Devices Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Endoscopic Bariatric Therapy Devices Sales by Region (2020-2031)
3.6.3 Asia Pacific Endoscopic Bariatric Therapy Devices Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Endoscopic Bariatric Therapy Devices Market Facts & Figures by Country
3.7.1 Latin America Endoscopic Bariatric Therapy Devices Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Endoscopic Bariatric Therapy Devices Sales by Country (2020-2031)
3.7.3 Latin America Endoscopic Bariatric Therapy Devices Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Endoscopic Bariatric Therapy Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Endoscopic Bariatric Therapy Devices Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Endoscopic Bariatric Therapy Devices Sales by Country (2020-2031)
3.8.3 Middle East and Africa Endoscopic Bariatric Therapy Devices Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Endoscopic Bariatric Therapy Devices Sales by Type (2020-2031)
4.1.1 Global Endoscopic Bariatric Therapy Devices Sales by Type (2020-2025)
4.1.2 Global Endoscopic Bariatric Therapy Devices Sales by Type (2026-2031)
4.1.3 Global Endoscopic Bariatric Therapy Devices Sales Market Share by Type (2020-2031)
4.2 Global Endoscopic Bariatric Therapy Devices Revenue by Type (2020-2031)
4.2.1 Global Endoscopic Bariatric Therapy Devices Revenue by Type (2020-2025)
4.2.2 Global Endoscopic Bariatric Therapy Devices Revenue by Type (2026-2031)
4.2.3 Global Endoscopic Bariatric Therapy Devices Revenue Market Share by Type (2020-2031)
4.3 Global Endoscopic Bariatric Therapy Devices Price by Type (2020-2031)
5 Segment by Application
5.1 Global Endoscopic Bariatric Therapy Devices Sales by Application (2020-2031)
5.1.1 Global Endoscopic Bariatric Therapy Devices Sales by Application (2020-2025)
5.1.2 Global Endoscopic Bariatric Therapy Devices Sales by Application (2026-2031)
5.1.3 Global Endoscopic Bariatric Therapy Devices Sales Market Share by Application (2020-2031)
5.2 Global Endoscopic Bariatric Therapy Devices Revenue by Application (2020-2031)
5.2.1 Global Endoscopic Bariatric Therapy Devices Revenue by Application (2020-2025)
5.2.2 Global Endoscopic Bariatric Therapy Devices Revenue by Application (2026-2031)
5.2.3 Global Endoscopic Bariatric Therapy Devices Revenue Market Share by Application (2020-2031)
5.3 Global Endoscopic Bariatric Therapy Devices Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Boston Scientific (Apollo Endosurgery)
6.1.1 Boston Scientific (Apollo Endosurgery) Company Information
6.1.2 Boston Scientific (Apollo Endosurgery) Description and Business Overview
6.1.3 Boston Scientific (Apollo Endosurgery) Endoscopic Bariatric Therapy Devices Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Boston Scientific (Apollo Endosurgery) Endoscopic Bariatric Therapy Devices Product Portfolio
6.1.5 Boston Scientific (Apollo Endosurgery) Recent Developments/Updates
6.2 ReShape Lifesciences
6.2.1 ReShape Lifesciences Company Information
6.2.2 ReShape Lifesciences Description and Business Overview
6.2.3 ReShape Lifesciences Endoscopic Bariatric Therapy Devices Sales, Revenue and Gross Margin (2020-2025)
6.2.4 ReShape Lifesciences Endoscopic Bariatric Therapy Devices Product Portfolio
6.2.5 ReShape Lifesciences Recent Developments/Updates
6.3 Allurion
6.3.1 Allurion Company Information
6.3.2 Allurion Description and Business Overview
6.3.3 Allurion Endoscopic Bariatric Therapy Devices Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Allurion Endoscopic Bariatric Therapy Devices Product Portfolio
6.3.5 Allurion Recent Developments/Updates
6.4 Helioscopie
6.4.1 Helioscopie Company Information
6.4.2 Helioscopie Description and Business Overview
6.4.3 Helioscopie Endoscopic Bariatric Therapy Devices Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Helioscopie Endoscopic Bariatric Therapy Devices Product Portfolio
6.4.5 Helioscopie Recent Developments/Updates
6.5 Endalis
6.5.1 Endalis Company Information
6.5.2 Endalis Description and Business Overview
6.5.3 Endalis Endoscopic Bariatric Therapy Devices Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Endalis Endoscopic Bariatric Therapy Devices Product Portfolio
6.5.5 Endalis Recent Developments/Updates
6.6 MEDSIL
6.6.1 MEDSIL Company Information
6.6.2 MEDSIL Description and Business Overview
6.6.3 MEDSIL Endoscopic Bariatric Therapy Devices Sales, Revenue and Gross Margin (2020-2025)
6.6.4 MEDSIL Endoscopic Bariatric Therapy Devices Product Portfolio
6.6.5 MEDSIL Recent Developments/Updates
6.7 Spatz Medical
6.7.1 Spatz Medical Company Information
6.7.2 Spatz Medical Description and Business Overview
6.7.3 Spatz Medical Endoscopic Bariatric Therapy Devices Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Spatz Medical Endoscopic Bariatric Therapy Devices Product Portfolio
6.7.5 Spatz Medical Recent Developments/Updates
6.8 Lexel
6.8.1 Lexel Company Information
6.8.2 Lexel Description and Business Overview
6.8.3 Lexel Endoscopic Bariatric Therapy Devices Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Lexel Endoscopic Bariatric Therapy Devices Product Portfolio
6.8.5 Lexel Recent Developments/Updates
6.9 Districlass Medical
6.9.1 Districlass Medical Company Information
6.9.2 Districlass Medical Description and Business Overview
6.9.3 Districlass Medical Endoscopic Bariatric Therapy Devices Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Districlass Medical Endoscopic Bariatric Therapy Devices Product Portfolio
6.9.5 Districlass Medical Recent Developments/Updates
6.10 Silimed
6.10.1 Silimed Company Information
6.10.2 Silimed Description and Business Overview
6.10.3 Silimed Endoscopic Bariatric Therapy Devices Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Silimed Endoscopic Bariatric Therapy Devices Product Portfolio
6.10.5 Silimed Recent Developments/Updates
6.11 Changzhou Panda Medical
6.11.1 Changzhou Panda Medical Company Information
6.11.2 Changzhou Panda Medical Description and Business Overview
6.11.3 Changzhou Panda Medical Endoscopic Bariatric Therapy Devices Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Changzhou Panda Medical Endoscopic Bariatric Therapy Devices Product Portfolio
6.11.5 Changzhou Panda Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Endoscopic Bariatric Therapy Devices Industry Chain Analysis
7.2 Endoscopic Bariatric Therapy Devices Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Endoscopic Bariatric Therapy Devices Production Mode & Process Analysis
7.4 Endoscopic Bariatric Therapy Devices Sales and Marketing
7.4.1 Endoscopic Bariatric Therapy Devices Sales Channels
7.4.2 Endoscopic Bariatric Therapy Devices Distributors
7.5 Endoscopic Bariatric Therapy Devices Customer Analysis
8 Endoscopic Bariatric Therapy Devices Market Dynamics
8.1 Endoscopic Bariatric Therapy Devices Industry Trends
8.2 Endoscopic Bariatric Therapy Devices Market Drivers
8.3 Endoscopic Bariatric Therapy Devices Market Challenges
8.4 Endoscopic Bariatric Therapy Devices Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Endoscopic Bariatric Therapy Devices market is projected to grow from US$ 156 million in 2025 to US$ 281 million by 2032, at a CAGR of 8.9% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-11
Pages: 158
USD 4900.00
(Single User License)
The global Endoscopic Bariatric Therapy Devices market was valued at US$ 156 million in 2025 and is anticipated to reach US$ 281 million by 2032, at a CAGR of 8.9% from 2026 to 2032.
Published Date: 2026-03-11
Pages: 120
USD 2900.00
(Single User License)
The global Endoscopic Bariatric Therapy Devices market size was US$ 156 million in 2025 and is forecast to reach a readjusted size of US$ 281 million by 2032 with a CAGR of 8.9% during the forecast period 2026-2032.
Published Date: 2026-03-11
Pages: 95
USD 4250.00
(Single User License)
The global market for Endoscopic Bariatric Therapy Devices was estimated to be worth US$ 156 million in 2025 and is projected to reach US$ 281 million, growing at a CAGR of 8.9% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 122
USD 3950.00
(Single User License)
The global Endoscopic Bariatric Therapy Devices market size was US$ 151 million in 2024 and is forecast to a readjusted size of US$ 260 million by 2031 with a CAGR of 8.9% during the forecast period 2025-2031.
Published Date: 2025-04-18
Pages: 100
USD 4250.00
(Single User License)
The global market for Endoscopic Bariatric Therapy Devices was estimated to be worth US$ 151 million in 2024 and is forecast to a readjusted size of US$ 260 million by 2031 with a CAGR of 8.9% during the forecast period 2025-2031.
Published Date: 2025-04-18
Pages: 129
USD 3950.00
(Single User License)
The global Endoscopic Bariatric Therapy Devices market is projected to grow from US$ 156 million in 2025 to US$ 260 million by 2031, at a Compound Annual Growth Rate (CAGR) of 8.9% during the forecast period.
Published Date: 2025-04-18
Pages: 164
USD 4900.00
(Single User License)
The global Endoscopic Bariatric Therapy Devices market is projected to grow from US$ 156 million in 2025 to US$ 281 million by 2032, at a CAGR of 8.9% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-11
Pages: 158
The global Endoscopic Bariatric Therapy Devices market was valued at US$ 156 million in 2025 and is anticipated to reach US$ 281 million by 2032, at a CAGR of 8.9% from 2026 to 2032.
Published: 2026-03-11
Pages: 120
The global Endoscopic Bariatric Therapy Devices market size was US$ 156 million in 2025 and is forecast to reach a readjusted size of US$ 281 million by 2032 with a CAGR of 8.9% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 95
The global market for Endoscopic Bariatric Therapy Devices was estimated to be worth US$ 156 million in 2025 and is projected to reach US$ 281 million, growing at a CAGR of 8.9% from 2026 to 2032.
Published: 2026-03-09
Pages: 122
The global Endoscopic Bariatric Therapy Devices market size was US$ 151 million in 2024 and is forecast to a readjusted size of US$ 260 million by 2031 with a CAGR of 8.9% during the forecast period 2025-2031.
Published: 2025-04-18
Pages: 100
The global market for Endoscopic Bariatric Therapy Devices was estimated to be worth US$ 151 million in 2024 and is forecast to a readjusted size of US$ 260 million by 2031 with a CAGR of 8.9% during the forecast period 2025-2031.
Published: 2025-04-18
Pages: 129
The global Endoscopic Bariatric Therapy Devices market is projected to grow from US$ 156 million in 2025 to US$ 260 million by 2031, at a Compound Annual Growth Rate (CAGR) of 8.9% during the forecast period.
Published: 2025-04-18
Pages: 164
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now